The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Value Is Anticipated For The Antiemetics And Antinauseants Market Over The Period 2026–2030?
The antiemetics and antinauseants market size has shown steady expansion in recent years. It is projected to increase from $8.48 billion in 2025 to $8.72 billion in 2026, achieving a compound annual growth rate (CAGR) of 2.8%. The expansion observed in the historic period stems from a rise in cancer incidence, an increase in surgical procedures, heightened awareness regarding chemotherapy side effects, the growth of hospital and clinic infrastructure, and advancements in antiemetic drug formulations.
The antiemetics and antinauseants market is projected to experience consistent expansion over the upcoming years. This market is anticipated to reach a value of $10.01 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 3.5%. Factors contributing to this growth during the projection period include a rising incidence of motion sickness, an expanding global elderly demographic, increased embrace of personalized medical treatments, advancements in new antiemetic drug delivery methods, and the broadening of outpatient chemotherapy and palliative care offerings. Key trends expected within the forecast timeframe encompass the evolution of personalized anti-nausea therapies, innovative drug delivery mechanisms, integrated combination therapy strategies, an increasing need for supportive care in chemotherapy, and an uptick in treatments for motion sickness and travel-associated conditions.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2441&type=smp
Which Economic Or Industry Drivers Are Impacting The Antiemetics And Antinauseants Market?
The rising incidence of tuberculosis is anticipated to boost the expansion of the antiemetics and antinauseants market. Tuberculosis (TB) is a contagious bacterial ailment that predominantly affects the lungs. These drugs, antiemetics and antinauseants, are utilized to manage nausea and vomiting that can arise from anti-tuberculosis treatments. For example, data from March 2025 by the Centers for Disease Control and Prevention, a US-based federal agency, indicated that in 2024, the United States recorded a provisional total of 10,347 tuberculosis cases, which translates to a rate of 3.0 cases per 100,000 population. This represented an increase of approximately 8% compared with 2023. Consequently, the growing occurrence of tuberculosis is projected to drive the expansion of the antiemetics and antinauseants market.
How Is The Antiemetics And Antinauseants Market Divided Into Its Major Segments?
The antiemetics and antinauseants market covered in this report is segmented –
1) By Drug: Dopamine antagonists, NK1 receptor antagonist, Antihistamines (H1 histamine receptor antagonists), Cannabinoids, Benzodiazepines, Anticholinergics, Steroids, 5-HT3 receptor antagonists, Other Drug Types
2) By Application: Chemotherapy, Motion sickness, Gastroenteritis, General anesthetics, Opioid analgesics, Dizziness, Pregnancy, Food poisoning, Emotional stress, Other Application Types
3) By End Users: Hospital, Medical Center, Clinic, Research Institutes
Subsegments:
1) By Dopamine Antagonists: Metoclopramide, Prochlorperazine, Domperidone
2) By NK1 Receptor Antagonists: Aprepitant, Fosaprepitant, Rolapitant
3) By Antihistamines (H1 Histamine Receptor Antagonists): Dimenhydrinate, Meclizine, Diphenhydramine
4) By Cannabinoids: Dronabinol, Nabilone
5) By Benzodiazepines: Lorazepam, Diazepam
6) By Anticholinergics: Scopolamine, Glycopyrrolate
7) By Steroids: Dexamethasone, Methylprednisolone
8) By 5-HT3 Receptor Antagonists: Ondansetron, Granisetron, Palonosetron
9) By Other Drug Types: Herbal Remedies, Acupressure Devices
How Are Trends Transforming The Antiemetics And Antinauseants Market Landscape?
Leading companies in the antiemetic and antinauseant markets are concentrating on novel product innovations, such as ready-to-use injectables, aimed at optimizing treatment procedures and boosting patient compliance. These pre-prepared formulations are designed to deliver immediate effectiveness, thereby decreasing the duration and complexity commonly associated with traditional injectable medications. For example, Amneal Pharmaceuticals, a US-based pharmaceutical company, launched FOCINVEZ in July 2024. This product represents the inaugural ready-to-use injectable formulation of fosaprepitant, intended to prevent both acute and delayed nausea and vomiting linked to highly emetogenic cancer chemotherapy. The product is provided in a 150 mg/50 mL vial, is free of Polysorbate 80, and eliminates the need for reconstitution or dilution, allowing for straightforward administration. FOCINVEZ has received approval for use in adults and pediatric patients aged six months and older and has been allocated a specific J-Code (J1434) for reimbursement purposes.
Who Are The Prominent Organizations Shaping The Antiemetics And Antinauseants Market?
Major companies operating in the antiemetics and antinauseants market are Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi SA, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Cipla Ltd., Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Baxter International Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Kyowa Hakko Kirin Pharma Co. Ltd., Daiichi Sankyo Company, Braun GmbH, Eisai Co. Ltd., Sun Pharmaceuticals Industries Ltd., Dr. Reddy’s Laboratories, Hikma Pharmaceuticals plc, IPCA Laboratories Ltd., Eagle Pharmaceuticals Inc., Cadila Pharmaceuticals Ltd., Bristol Laboratories Ltd., Tesaro Inc., SRS Pharmaceuticals Pvt. Ltd., Acacia Pharma Ltd., Algen Healthcare Ltd., Mirabilia Sciences Pvt. Ltd., Helsinn Healthcare SA
Read the full antiemetics and antinauseants market report here:
https://www.thebusinessresearchcompany.com/report/antiemetics-and-antinauseants-global-market-report
What Are The Top-Performing Regions Within The Antiemetics And Antinauseants Market?
North America was the largest region in the drugs for antiemetics and antinauseants market in 2025. The Middle East is expected to be the fastest-growing region in the global antiemetics and antinauseants market share. The regions covered in the antiemetics and antinauseants market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Antiemetics And Antinauseants Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=2441&type=smp
Browse Through More Reports Similar to the Global Antiemetics And Antinauseants Market 2026, By The Business Research Company
Antiemetics And Antinauseants Market Report 2026
https://www.thebusinessresearchcompany.com/report/antiemetics-and-antinauseants-global-market-report
Anti Infective Drugs Market 2026
https://www.thebusinessresearchcompany.com/report/anti-infective-drugs-market
Anticholinergic Drugs Market Report 2026
https://www.thebusinessresearchcompany.com/report/anticholinergic-drugs-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model